NGSX Insider Trading Activity and SEC Form 4 Filings
NGSX insider trading summary
No open-market insider purchases or sales of NeurogesX Inc (NGSX) have been reported on SEC Form 4 in the past 12 months.
Latest NGSX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 10, 2011 | Moshe Arkin | 10% Owner | Sell | $165K (82,109 @ $2.00) |
| Aug 10, 2011 | M. Arkin (1999) Ltd. | Insider | Sell | $165K (82,109 @ $2.00) |
| Aug 10, 2011 | Doron Breen | Insider | Sell | $165K (82,109 @ $2.00) |
| Aug 10, 2011 | Sphera Funds Management Ltd. | Insider | Sell | $165K (82,109 @ $2.00) |
| Aug 10, 2011 | Israel Mor | Insider | Sell | $165K (82,109 @ $2.00) |
| Aug 10, 2011 | Ron Senator | Insider | Sell | $165K (82,109 @ $2.00) |
| Aug 9, 2011 | Israel Mor | Insider | Sell | $175K (81,359 @ $2.15) |
| Aug 9, 2011 | Doron Breen | Insider | Sell | $175K (81,359 @ $2.15) |
| Aug 9, 2011 | Ron Senator | Insider | Sell | $175K (81,359 @ $2.15) |
| Aug 9, 2011 | Sphera Funds Management Ltd. | Insider | Sell | $175K (81,359 @ $2.15) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.